Post-IPO Equity - Selecta Biosciences
Investment Firm
Overview
Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.
Announced Date
Nov 13, 2023
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
 Timothy A. Springer |
Round Details and Background
Selecta Biosciences raised $60250000 on 2023-11-13 in Post-IPO Equity
Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.
Company Funding History
20
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Oct 27, 2011 |  Series D - Selecta Biosciences | 1 | - | 47.3M |
| Aug 17, 2010 | Grant - Selecta Biosciences | 1 | - | 3.0M |
| Apr 05, 2010 | Series C - Selecta Biosciences | 5 | - | 15.0M |
| Feb 25, 2009 | Series B - Selecta Biosciences | 4 | - | 15.1M |
Recent Activity
There is no recent news or activity for this profile.